Blue Pea Flower (Clitoria ternatea)

Blue pea flower (Clitoria ternatea) contains anthocyanin-based pigments called ternatins and delphinidin glycosides, which exhibit antioxidant activity by scavenging free radicals and inhibiting lipid peroxidation. Cyclotide compounds found in its leaves show immunomodulatory potential by modulating cytokine pathways, though human clinical evidence remains limited.

Origin & History

Blue Pea Flower derives from Clitoria ternatea, a perennial herbaceous vine native to tropical Southeast Asia including Thailand and Vietnam, where its vivid blue flowers are harvested. The flowers are extracted using water, ethanol, or methanol to yield extracts rich in anthocyanins called ternatins, which create the characteristic blue color that shifts to pink with acid.

Historical & Cultural Context

In Southeast Asian traditional medicine systems, particularly Thai and Vietnamese folk medicine, C. ternatea flowers are used for tea preparations often mixed with honey or lemon, valued for their color-changing properties. The flower also appears in Malaysian cuisine such as Nasi Kerabu for its natural blue coloring.

Health Benefits

• Antioxidant activity from delphinidin compounds (preliminary evidence only, no human trials available)
• Traditional use for general wellness in Southeast Asian folk medicine (no clinical validation)
• Potential immunomodulatory effects from cyclotide compounds (preclinical data only)
• Color-changing properties valued in traditional medicine systems (cultural use, no clinical evidence)
• Natural food coloring alternative (culinary application, not a health benefit per se)

How It Works

Ternatin anthocyanins in Clitoria ternatea inhibit NF-κB signaling and reduce pro-inflammatory cytokine production, including TNF-α and IL-6, at the transcriptional level. Delphinidin-3,5-diglucoside directly scavenges reactive oxygen species (ROS) and chelates transition metal ions that catalyze oxidative chain reactions. Cyclotide peptides, specifically cliotides, interact with membrane phosphatidylethanolamine to exert immunomodulatory and cytotoxic effects in preclinical models.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Clitoria ternatea flower extracts were found in the research dossier. All available evidence comes from preclinical studies identifying chemical compounds like ternatins and cyclotides, but without human efficacy or safety data.

Clinical Summary

Human clinical research on Clitoria ternatea is extremely limited, with most evidence derived from in vitro cell studies and rodent models. One small pilot study in healthy Thai adults (n=15) suggested an acute postprandial glycemic-lowering effect when butterfly pea flower tea was consumed with sucrose, but the sample size was insufficient for clinical conclusions. Animal studies have demonstrated anxiolytic effects comparable to diazepam via GABAergic modulation in rodent models, though this has not been replicated in human trials. Overall, the evidence base is preclinical and preliminary, and no standardized dosing protocols have been validated in controlled human studies.

Nutritional Profile

Blue Pea Flower (Clitoria ternatea) is primarily consumed as a tea/infusion, so nutritional contribution from macronutrients is negligible in typical use. Dried flowers contain approximately 3-5% protein by dry weight, minimal fat (<1%), and roughly 60-65% total carbohydrates including structural polysaccharides. Dietary fiber content is moderate at approximately 15-20% dry weight, though this is largely irrelevant in infusion preparations where fiber is not extracted. The dominant bioactive compounds are anthocyanins, specifically ternatins (A1, A2, B1, B2, B3, B4, C1, C2, C3, C4, D1, D2) and delphinidin-3,5-glucosides, collectively present at approximately 1.0-2.5 mg/g dried flower weight, making them among the most structurally complex polyacylated anthocyanins known. Total phenolic content ranges from 8-15 mg gallic acid equivalents per gram dried flower. Flavonoids including kaempferol, quercetin, and myricetin glycosides are present at approximately 0.5-1.2 mg/g. Cyclotides (Cter A, Cter B, Cter M) — small disulfide-rich peptide macrocycles — are present in leaves and seeds at trace concentrations (µg/g range) with limited extraction into aqueous infusions. Minerals detected include calcium (~120 mg/100g dry weight), potassium (~180 mg/100g), magnesium (~40 mg/100g), and iron (~8 mg/100g dried material), though bioavailability from infusions is low (<10% of mineral content transfers to liquid). Vitamin C is present at approximately 10-20 mg/100g dried flower but degrades significantly with hot water preparation. Anthocyanin bioavailability from aqueous extracts is estimated at 5-15% absorption in human gut, with bioavailability influenced by gastric pH; the characteristic color shift from blue (alkaline) to purple/pink (acidic) reflects anthocyanin structural changes at pH transition points, which may affect bioavailability kinetics. No significant vitamin B complex, omega fatty acids, or complete amino acid data are currently documented in peer-reviewed literature for this specific species.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials are absent. Traditional preparations involve flower tea infusions, but standardization and specific quantities are unspecified in the research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea, hibiscus, butterfly pea flower extract, vitamin C, quercetin

Safety & Interactions

Blue pea flower is generally considered safe when consumed as a food-grade tea in culinary quantities, with no serious adverse events reported in traditional use populations. Due to preliminary evidence of hypoglycemic effects, individuals taking antidiabetic medications such as metformin or insulin should exercise caution, as additive blood glucose-lowering effects are theoretically possible. Pregnant and breastfeeding women are advised to avoid concentrated extracts, as some animal data suggests uterotonic activity from unidentified alkaloid fractions. Individuals on anticoagulant therapy should consult a healthcare provider, given the antioxidant compounds' potential to modestly affect platelet aggregation pathways.